7月16日，美国总统特朗普在签署《全面遏制芬太尼贩运法案》前的几小时，突然话锋一转："我认为中国一直在帮助我们。"他特意强调中国在芬太尼问题 上"正在迈开大步"，甚至暗示中国"想做点什么"的态度值得肯定。戏剧性的是，当同日晚些时候特朗普真正落笔签署法案后，他的调门又陡然逆转。他再次 拾起那些被事实反复驳斥的说辞，声称"中国提供了大部分芬太尼"，甚至危言耸听地表示"有些人会说中国提供了所有芬太尼"。 这种自相矛盾的表演背后，关税——这个中方最关切的实质议题——他却绝口不提。特朗普对芬太尼问题的态度摇摆，始终与关税政策紧密相连。今年2 月，他就以中国"未能阻止芬太尼流入"为由，宣布对所有中国输美商品加征10%关税。这些指控出台时，美国海关边境保护局的记录却显示：自2019年5月 中国实施全球最严格的整类列管政策以来，美方再未查获过来自中国的芬太尼类物质。中方的反应迅速而有力。 在特朗普3月3日又迅速将税率提高至20%的第二天，中国就对美国农产品加征报复性关税，并精准"剑指"数十家美国企业。贸易关税争端迅速不断加码升 级，直到5月日内瓦会谈才达成临时休战——双方同意将双边关税下调115%，各自保留10%的"底线"。 ...

众所周知，美国对中国征收245%的巨额关税，最大的原因就是芬太尼。特朗普政府把关税大棒包装 成"禁毒神器"，声称中国是"美国芬太尼危机的罪魁祸首"。不仅如此，特朗普政府还一直警告中国，如 果不能有效禁止芬太尼出口，美国将对中国实施更加严厉的制裁。 事实上，中国是全球第一个整类列管芬太尼类物质的国家，从2019年就已经开始了。在特朗普的第一个 任期内，中美达成协议后，中方对芬太尼实施了管控。数据显示，中方此举起到了立竿见影的效果，美 国国内的芬太尼药物价格上涨，使得很多人无法获取芬太尼，进而减少了更多人死亡。 美国民众吸食芬太尼 美国政府最近又上演了一出"魔幻现实主义大戏"。特朗普团队一边举着"打击芬太尼"的正义大旗对中国 加征关税，另一边却被事实啪啪打脸，中国救了近千条美国人命。 芬太尼 日前，《南华早报》报道称，美国研究所的一项最新研究表明，中国不仅没有向美国输送芬太尼，反而 因为在2019年就实施的芬太尼出口禁令，挽救了近千名美国人的性命。这一数据一经公布，立刻引发国 际热议，也揭开了特朗普政府的虚伪面具。 美方数据显示，美国每年都有上万人因过量使用芬太尼而死亡。尽管美国声称合成芬太尼的前体化学品 都产自 ...

Core Viewpoint - The recent comments by a U.S. mayor about distributing fentanyl to the homeless highlight the severity of the fentanyl crisis in the U.S., which is often blamed on China, undermining cooperation in drug control between the two nations [1][4]. Group 1: U.S. Fentanyl Crisis - The U.S. has not permanently classified fentanyl, leading to worsening drug abuse and overdose issues, with synthetic opioids causing 75,000 overdose deaths in 2023, accounting for nearly 70% of all drug overdose deaths [2]. - The U.S. consumes 80% of the world's opioids despite having less than 5% of the global population, indicating a significant public health crisis [2]. - A poll by the Sihe Zhiyuan Foundation shows that most Americans believe drug cartels, users, and the government are responsible for the fentanyl crisis, suggesting a need for comprehensive policy reform [2]. Group 2: China's Drug Control Efforts - China maintains a "zero tolerance" policy towards drugs, including fentanyl, and has taken significant steps in drug control, including the comprehensive classification of fentanyl in 2019, making it the first country to do so [3]. - Since China's classification of fentanyl, there have been no reported cases of fentanyl smuggling from China to the U.S., as acknowledged by the U.S. State Department [3]. - China continues to enhance its control over precursor chemicals and collaborates with countries like the U.S. and Mexico to combat the issue of fentanyl and its precursors [3]. Group 3: U.S.-China Cooperation - The establishment of the U.S.-China drug control cooperation working group in 2024 provides a platform for both countries to address global drug issues collaboratively [4]. - Ongoing technical exchanges and regular communication between the two nations' drug enforcement agencies aim to strengthen cooperation in tackling the fentanyl crisis [4]. - China's strong opposition to the U.S. imposing tariffs under the pretext of the fentanyl issue emphasizes the need for mutual respect and factual acknowledgment in bilateral relations [4].